Health Care · Surgical & Medical Instruments & Apparatus · OTC · CIK 1327273 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.48Day −5.00%Mkt cap $843,0691Y −93.5%Off 52W high −94.6%Vol (1Y) 134.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,366 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.3% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−4.01% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-10-01 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$398,000 |
| Earnings (TTM)-$28.9M |
| Net margin−7266.1% |
| Sales growth 3Y−33.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−84.6% |
| 1Y−93.5% |
| 3Y−99.7% |
| 5Y−99.9% |
| Since incept. (ann.)−73.8% |
Total return through 2026-07-29 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)134.4% |
| Ann. volatility (3Y)215.7% |
| Sharpe (1Y)−1.25 |
| Sharpe (3Y)−0.16 |
| Max drawdown (1Y)−95.1% |
| Max drawdown (3Y)−99.9% |
| Beta (3Y vs SPY)2.72 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 104,059 | $51,103 | 5.86% | −40.6% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2025-12-31 | 2026-03-31 | — | — | $7,000 | −96.7% |
| 2025-09-30 | 2025-11-12 | −$3.38 | — | $25,000 | −87.2% |
| 2025-06-30 | 2025-08-12 | −$5.51 | — | $183,000 | −69.4% |
| 2025-03-31 | 2025-05-06 | −$6.50 | — | $183,000 | −65.6% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-10-01 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
